Authors: McConnell, JD Stoner, E

Citation: Jd. Mcconnell et E. Stoner, 5 alpha-reductase inhibitors, ADV PROTEIN, 56, 2001, pp. 143-180

Authors: Ghosh, S Bhattacharya, P Stoner, E Singh, J Jiang, H Nuttinck, S Laskar, J

Citation: S. Ghosh et al., Temperature-dependent measurement of Auger recombination in self-organizedIn0.4Ga0.6As/GaAs quantum dots, APPL PHYS L, 79(6), 2001, pp. 722-724

Authors: Hariraj, R Stoner, E Jader, S Preston, DM

Citation: R. Hariraj et al., Drug points - Prolonged cholestasis associated with irbesartan, BR MED J, 321(7260), 2000, pp. 547-547

Authors: Marberger, MJ Andersen, JT Nickel, JC Malice, MP Gabriel, M Pappas, F Meehan, A Stoner, E Waldstreicher, J

Citation: Mj. Marberger et al., Prostate volume and serum prostate-specific antigen as predictors of acuteurinary retention - Combined experience from three large multinational placebo-controlled trials, EUR UROL, 38(5), 2000, pp. 563-568

Authors: Hudson, PB Boake, R Trachtenberg, J Romas, NA Rosenblatt, S Narayan, P Geller, J Lieber, MM Elhilali, M Norman, R Patterson, L Perreault, JP Malek, GH Bruskewitz, RC Roy, JB Ko, A Jacobsen, CA Stoner, E

Citation: Pb. Hudson et al., Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years, UROLOGY, 53(4), 1999, pp. 690-695

Authors: Marks, LS Partin, AW Dorey, FJ Gormley, GJ Epstein, JI Garris, JB Macairan, ML Shery, ED Santos, PB Stoner, E deKernion, JB

Citation: Ls. Marks et al., Long-term effects of finasteride on prostate tissue composition, UROLOGY, 53(3), 1999, pp. 574-580